DJIA 17,818.07 4.68 0.03%
NASDAQ 5,132.08 15.94 0.31%
S&P 500 2,092.02 3.15 0.15%
market minute promo

Celgene (NASDAQ: CELG)

112.78 0.43 (0.38%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

CELG $112.71 0.32%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $112.66
Previous Close $112.35
Daily Range $112.02 - $113.05
52-Week Range $92.98 - $140.72
Market Cap $88.6B
P/E Ratio 56.46
Dividend (Yield) $0.00 (0.0%)
Volume 1,024,139
Average Daily Volume 4,798,817
Current FY EPS $4.19




Drug Makers

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website:

News & Commentary Rss Feed

1 Healthcare Stock That Has It All

The healthcare sector is packed with high-growth, but risky, investment opportunities. However, this healthcare stock appears to have all your bases covered.

Short Sellers Run for Cover From Major Biotechs

Johnson & Johnson's Latest FDA Approval Could Spell Problems for Amgen

Johnson & Johnson's newly approved multiple myeloma drug, Darzalex, is worth keeping an eye on for a number of reasons.

3 Drugs Stocks Dragging The Industry Down

Biotechs Can't Be Ignored

IYH, AMGN, CELG, LLY: ETF Outflow Alert

Project $1M: Achieving A $1M Portfolio With Growth Stocks Pt. 3

Market Update: The 'Pullback' In The S&P Was Short Lived, The Market Is In Rally Mode Despite World

Market Update: The 'Pullback' In The S&P Was Short Lived, The Market Is In Rally Mode Despite World Events And Interest Rate Headlines

Amgen's Multiple Myeloma Drug Kyprolis Gains EU Approval

Cancer Immunotherapy ETF Takes Curious Approach To Asset Allocation

See More CELG News...

CELG's Top Competitors

CELG $112.78 (0.38%)
Current stock: CELG
AMGN $163.24 (-0.43%)
Current stock: AMGN
GILD $107.96 (0.17%)
Current stock: GILD
$0.00 (0.00%)
Current stock: